Viva Biotech Holdings in brief
Viva Biotech Holdings is a listed company in the Biotechnology industry, based in China. Its last known market value was $266 M (January 2024); there is no current figure. In the year to Dec 2021 it had sales of $306 M and a net profit of $42 M, about 14 cents of profit for every dollar of sales. Its shares trade under the symbol 1873.HK (HKeX).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Viva Biotech Holdings share price · HKeX (1873.HK)
| Date | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 1.155 | 1.130 | 1.145 | -1.7% | 1.3 M |
| Nov 18, 2026 | 1.175 | 1.140 | 1.165 | 0.0% | 2.0 M |
| Nov 17, 2026 | 1.215 | 1.165 | 1.165 | -3.3% | 4.3 M |
| Nov 16, 2026 | 1.265 | 1.200 | 1.205 | -3.6% | 3.4 M |
| Nov 13, 2026 | 1.295 | 1.245 | 1.250 | -3.5% | 2.8 M |
| Nov 12, 2026 | 1.330 | 1.285 | 1.295 | -0.8% | 1.1 M |
| Nov 11, 2026 | 1.330 | 1.290 | 1.305 | -1.1% | 1.2 M |
| Nov 10, 2026 | 1.355 | 1.320 | 1.320 | +1.1% | 796,000 |
| Nov 9, 2026 | 1.350 | 1.300 | 1.305 | -1.5% | 4.6 M |
| Nov 6, 2026 | 1.355 | 1.280 | 1.325 | -1.5% | 7.2 M |
| Nov 5, 2026 | 1.370 | 1.295 | 1.345 | +4.3% | 3.7 M |
| Nov 4, 2026 | 1.300 | 1.210 | 1.290 | +6.2% | 3.6 M |
| Nov 3, 2026 | 1.250 | 1.190 | 1.215 | -2.8% | 4.5 M |
| Nov 2, 2026 | 1.290 | 1.230 | 1.250 | 0.0% | 1.5 M |
| Oct 30, 2026 | 1.300 | 1.230 | 1.250 | -1.6% | 3.1 M |
| Oct 29, 2026 | 1.335 | 1.270 | 1.270 | -4.2% | 2.7 M |
| Oct 28, 2026 | 1.340 | 1.260 | 1.325 | +6.9% | 3.3 M |
| Oct 27, 2026 | 1.270 | 1.240 | 1.240 | -0.8% | 3.3 M |
| Oct 26, 2026 | 1.265 | 1.235 | 1.250 | -2.3% | 2.6 M |
| Oct 23, 2026 | 1.290 | 1.230 | 1.280 | -1.5% | 5.3 M |
| Oct 22, 2026 | 1.350 | 1.280 | 1.300 | -3.7% | 6.0 M |
| Oct 21, 2026 | 1.430 | 1.345 | 1.350 | -0.7% | 3.9 M |
| Oct 20, 2026 | 1.410 | 1.320 | 1.360 | +0.4% | 3.6 M |
| Oct 16, 2026 | 1.415 | 1.320 | 1.355 | +2.3% | 4.7 M |
| Oct 15, 2026 | 1.370 | 1.320 | 1.325 | -3.3% | 4.2 M |
| Oct 14, 2026 | 1.395 | 1.345 | 1.370 | -0.4% | 2.2 M |
| Oct 13, 2026 | 1.445 | 1.360 | 1.375 | -5.2% | 5.5 M |
| Oct 12, 2026 | 1.600 | 1.450 | 1.450 | -6.1% | 5.5 M |
| Oct 9, 2026 | 1.590 | 1.435 | 1.545 | +1.6% | 10.7 M |
| Oct 8, 2026 | 1.725 | 1.525 | 1.520 | — | 9.3 M |
Prices in HKD from Hong Kong Exchanges (no opening price in its report); the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Viva Biotech Holdings share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in China: #1,715 (Jan 2020) · #1,163 (Jan 2021) · #2,414 (Jan 2022) · #4,001 (Dec 2022) · #3,945 (Jul 2023) · #4,827 (Jan 2024)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 13.7%
- Operating margin
- —
- Return on equity
- 7.4%
- Liabilities / assets
- 51.3%
Annual results
- Revenue
- $306 M
- Operating income
- —
- Net income
- $42 M
Dec-2021 ending year
Balance sheet
- Total assets
- $1.2 B
- Total liabilities
- $601 M
- Total equity
- $569 M
Dec-2021 ending year
Mutual funds holding Viva Biotech Holdings#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 6.64 M | $1 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc. | 3.33 M | $0 M | — | <0.01% | −1.6% | Jun 30, 2026 |
| 🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP | 2.09 M | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust | 2.12 M | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 1.07 M | $0 M | — | <0.01% | −59% | Jul 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 984,500 | $0 M | — | <0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP | 791,000 | $0 M | — | <0.01% | −33% | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 701,500 | $0 M | — | 0.01% | −10% | Jun 30, 2026 |
| 🇺🇸 State Street Emerging Markets Enhanced Index PortfolioBrighthouse Investment Advisers, LLC | 637,000 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 427,500 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity FundAmerican Century ETF Trust | 313,500 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 World ex U.S. Targeted Value PortfolioDimensional Fund Advisors LP | 265,500 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP | 187,500 | $0 M | — | <0.01% | −60% | Jul 31, 2026 |
| 🇺🇸 Emerging Markets Sustainability Core 1 PortfolioDimensional Fund Advisors LP | 172,000 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust | 166,500 | $0 M | — | 0.02% | no change | May 31, 2026 |
| 🇺🇸 Emerging Markets Targeted Value PortfolioDimensional Fund Advisors LP | 133,500 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Responsible Emerging Markets Equity ETFAmerican Century ETF Trust | 54,500 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP | 48,000 | $0 M | — | <0.01% | −96% | Jul 31, 2026 |
| 🇺🇸 SA Emerging Markets Value FundFocus Advisor Solutions, LLC | 45,500 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis Emerging Markets Value ETFAmerican Century ETF Trust | 9,000 | $0 M | — | <0.01% | no change | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 20 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
How Viva Biotech Holdings compares in Biotechnology
- Revenue$306 M · higher than 82% of 647
- Net margin13.7% · higher than 81% of 408
- 🇩🇪 MorphoSys AG$307 M
- 🇮🇸 Alvotech$1.3 B
- 🇺🇸 CorMedix Inc.$652 M
- 🇨🇳 Anhui Anke Biotechnology (Group)$2.2 B
- 🇺🇸 Rigel Pharmaceuticals, Inc.$955 M
- 🇺🇸 Xeris Pharmaceuticals$1.8 B
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Viva Biotech Holdings🇨🇳 | $266 M | — | 13.7% | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Dec-2021 ending year
- Balance sheet:
- Dec-2021 ending year
- Profile updated:
- Nov 15, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Viva Biotech Holdings? Verify and update this profile — free
Show Viva Biotech Holdings's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.